View Post

CRISPR gene editing may halt progression of triple-negative breast cancer

In In The News by Barbara Jacoby

Source: Boston Children’s Hospital From: A tumor-targeted CRISPR gene editing system, encapsulated in a nanogel and injected into the body, could effectively and safely halt the growth of triple-negative breast cancer, report researchers at Boston Children’s Hospital. Their proof-of-principle study, conducted in human tumor cells and in mice, suggests a potential genetic treatment for triple-negative breast cancer, which has …